- Home
- Products
- Customized FluoroAb™
- IgG Fab
- Anti-IgG Fab MAb (Clone 1)-iFluor® 488 Succinimidyl Ester
Anti-IgG Fab MAb (Clone 1)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9794)
- TARGET
- ANTIBODY
- DYE
- Name
- IgG Fab
- Overview
- Anti-human IgG Fab specific polyclonal IgG antibody (Clone 1)
- Species Reactivity
- Human
- Name
- iFluor® 488 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 491/516
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS9794. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-AA-063 | Anti-HIgG(Fab)-N-MMAF ADC | Noncleavable linkers | MMAF |
| ADC-AA-018 | anti-HIgG(Fab)-N-DM1 ADC | Noncleavable linkers | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-AA-064 | Anti-HIgG(Fab)-C-MMAF ADC | Cleavable linkers | MMAF |
| ADC-AA-017 | anti-HIgG(Fab)-C-MMAE ADC | Cleavable linkers | MMAE (Monomethyl auristatin E) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-MS4A1 MAb (Clone 24)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10124)
- Anti-CD70 MAb (Clone 6)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS1990)
- Anti-IL23A MAb (Clone 2)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14470)
- Anti-SDC1 MAb (Clone 2)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6962)
- Anti-TNFRSF17 MAb (Clone 29)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7104)
- Clenoliximab-iFluor 532 (CAT#: ADC-FL-688)
- Arcitumomab-OGreen (CAT#: ADC-FL-935)
- Anti-Rabies Virus Glycoprotein MAb (Clone 7)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS12325)
- Anti-MSTN MAb (Clone 8)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4503)
- Anti-CD40LG MAb (Clone 2)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9413)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
